Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine
Crossref DOI link: https://doi.org/10.1186/s12929-016-0238-3
Published Online: 2016-01-25
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gableh, Fateme
Saeidi, Mohsen
Hemati, Shaghayegh
Hamdi, Kasra
Soleimanjahi, Hoorieh
Gorji, Ali
Ghaemi, Amir
Funding for this research was provided by:
Research Deputy at Golestan Medical University (35/693)
